Elzonris 1mg / ml

Elzonris 1mg / ml is a medicine authorised by Swissmedic under authorisation number 68797. The authorisation holder is Stemline Therapeutics Switzerland GmbH. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 03 February 2023 and the authorisation is limited until 02 February 2028. ATC code L01XX67 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 68797
  • ATC L01XX67
  • Biotechnological medicines
Authorisation data
Authorisation number68797
NameElzonris 1mg / ml
Full nameElzonris 1mg / ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderStemline Therapeutics Switzerland GmbH
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01XX67
First authorisation03 February 2023
Authorisation validity02 February 2028
Strengths
No.NameDispensing categoryAuthorisation date
1Elzonris 1mg / ml, Konzentrat zur Herstellung einer InfusionslösungA03 February 2023

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01XX6707.16.4.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Elzonris 1mg / ml authorised in Switzerland?

Yes. Elzonris 1mg / ml is authorised by Swissmedic under authorisation number 68797, data as of 01 September 2026. The authorisation is limited until 02 February 2028.

Which dispensing category does Elzonris 1mg / ml have?

Elzonris 1mg / ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Elzonris 1mg / ml?

The authorisation holder is Stemline Therapeutics Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com